The role of positron emission tomography in management of small cell lung cancer
Authors:
- P. HulsePHP. Hulse
- P. LoriganPLP. Lorigan
- C. Faivre-FinnCFC. Faivre-Finn
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 73 (2) , 121-126
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Treatment of limited small cell lung cancer: an old or new challenge?Current Opinion in Oncology, 2011
- The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- Radiotherapy for small-cell lung cancer—Where are we heading?Lung Cancer, 2009
- Evidence for Management of Small Cell Lung CancerChest, 2007
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseJournal of Clinical Oncology, 2006
- Management of small-cell lung cancerAnnals of Oncology, 2005
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104Journal of Clinical Oncology, 2002
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.Journal of Clinical Oncology, 1992
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989